Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure

被引:114
作者
Carcillo, JA
Doughty, L
Kofos, D
Frye, RF
Kaplan, SS
Sasser, H
Burckart, GJ
机构
[1] Childrens Hosp Pittsburgh, Div Crit Care Med, Pittsburgh, PA 15123 USA
[2] Univ Pittsburgh, Sch Med, Dept Anesthesiol & Crit Care Med & Pediat, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Sch Med, Ctr Clin Pharmacol, Pittsburgh, PA 15213 USA
[4] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA 15213 USA
关键词
antipyrine; nitric oxide; interleukin-6;
D O I
10.1007/s00134-003-1758-3
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Antipyrine metabolism is a "gold standard" measure of mixed cytochrome P450 (CYP) mediated drug metabolism in humans. Cytokines (e.g., interleukin-6) and nitric oxide reduce CYP 450 activity in vitro and in vivo. Because interleukin-6 and nitric oxide production increases in children with sepsis-induced multiple organ failure, we hypothesized impaired CYP 450 mediated drug metabolism in this population. Methods: Fifty-one consecutive children with sepsis and six critically ill children without sepsis were enrolled and given 18 mg/kg antipyrine per NG. Plasma antipyrine elimination rate, elimination half-life, and apparent oral clearance were measured and calculated. Plasma interleukin-6 and nitrite plus nitrate levels were measured and organs failing scored on days 1-3 of sepsis. Results: Children with sepsis had a twofold reduction in antipyrine clearance. Children with persistent failure of three or more organs had a fourfold reduction in antipyrine clearance. Antipyrine clearance was inversely correlated to circulating interleukin-6 and nitrite plus nitrate levels and to number of organ failures. Conclusions: Interpretation CYP 450 mediated drug metabolism is decreased in children with sepsis, related in part to the degree of inflammation and organ failure. For drugs metabolized by CYP 450 enzymes there is an urgent need to reevaluate the use of standard drug dosage schedules in the sepsis population.
引用
收藏
页码:980 / 984
页数:5
相关论文
共 22 条
[1]  
ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707
[2]   The sepsis syndrome - Definition and general approach to management [J].
Bone, RC .
CLINICS IN CHEST MEDICINE, 1996, 17 (02) :175-&
[3]  
CHANG KC, 1978, LANCET, V1, P1132
[4]   STUDIES ON THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN MAN .1. ORAL-ADMINISTRATION OF 250, 500 AND 1000 MG TO HEALTHY-VOLUNTEERS [J].
DANHOF, M ;
BREIMER, DD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (06) :529-537
[5]   Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis [J].
Doughty, L ;
Carcillo, JA ;
Kaplan, S ;
Janosky, J .
CRITICAL CARE MEDICINE, 1998, 26 (01) :157-162
[6]   Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure [J].
Doughty, LA ;
Kaplan, SS ;
Carcillo, JA .
CRITICAL CARE MEDICINE, 1996, 24 (07) :1137-1143
[7]  
EICHELBAUM M, 1982, ARZNEIMITTEL-FORSCH, V32-1, P575
[8]   Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydromethylantipyrine, and norantipyrine formation [J].
Engel, G ;
Hofmann, U ;
Heidemann, H ;
Cosme, J ;
Eichelbaum, M .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (06) :613-623
[9]   ANTIPYRINE CLEARANCE PER UNIT VOLUME LIVER - ASSESSMENT OF HEPATIC-FUNCTION IN CHRONIC LIVER-DISEASE [J].
HOMEIDA, M ;
ROBERTS, CJC ;
HALLIWELL, M ;
READ, AE ;
BRANCH, RA .
GUT, 1979, 20 (07) :596-601
[10]  
KRAEMER MJ, 1982, PEDIATRICS, V69, P476